Qiang Lu
About Qiang Lu
Qiang Lu serves as the Executive Director and Head of Clinical Pharmacology and Bioanalysis at Deciphera Pharmaceuticals, a position he has held since 2022. He has extensive experience in pharmacometrics and has previously worked at Cognigen Corporation and Sanofi.
Current Role at Deciphera Pharmaceuticals
Qiang Lu serves as the Executive Director and Head of Clinical Pharmacology and Bioanalysis at Deciphera Pharmaceuticals. He has held this position since 2022, contributing to the company's focus on developing innovative cancer therapies. His role involves overseeing clinical pharmacology strategies and bioanalytical methods to support drug development initiatives.
Previous Experience at Cognigen Corporation
Before joining Deciphera Pharmaceuticals, Qiang Lu worked at Cognigen Corporation for six years, from 2007 to 2013. During his tenure, he specialized in pharmacometrics, applying quantitative methods to improve drug development processes. His experience at Cognigen laid a strong foundation for his subsequent roles in clinical pharmacology.
Tenure at Sanofi
Qiang Lu was employed at Sanofi from 2013 to 2022, where he held the position of Modeling and Simulation U.S. Head in the Pharmacokinetics, Dynamics & Metabolism department. His nine years at Sanofi involved leading efforts in modeling and simulation to enhance drug development and regulatory submissions.
Educational Background
Qiang Lu has an extensive educational background in pharmaceutical sciences. He studied at China Pharmaceutical University from 1993 to 1997, followed by Peking University from 1997 to 2000. He then attended The Ohio State University, where he completed his studies from 2000 to 2005. He furthered his education at the University at Buffalo, focusing on Pharmacy and Pharmaceutical Sciences from 2005 to 2007.